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Abstract Methods: WGS was performed on ten members of this family  using  the  Il-lumina  HiSeq2000  platform,  with 
four  (the  two  affected  boys  and  their  parents)  being 
additionally sequenced using the CG WGS platform. CG 
data analysis was performed by CG, using their version 
2.0 pipeline. Multiple variant calling pipelines were used 
to  detect  SNVs,  INDELs,  STRs  and  CNVs.   Disease 
variant prioritization was performed using ANNOVAR, 
Golden  Helix  SVS  v8.1.4  and  GEMINI  v0.9.1,  and 
VAAST v2.0.
Results:  CG  WGS  covered  >85%  of  the  genome  and 
>90%  of  the  exome,  both  with  20  or  more  reads. 
Illumina  WGS covered  >90% of  the  genome with  30 
reads  or  more  and  with  >80% of  the  bases  having  a 
quality score of >30. On average, we find a 2.4 to 14.0 
mean fold difference in the number of variants detected 
as being relevant for various disease models when using 
different sets of sequencing data and analysis pipelines. 
We  found  a  number  of  putative  genetic  variants  and 
archive them here.
Background:  We  describe  a  comprehensive  whole 
genome sequencing (WGS) study using the Illumina and 
Complete Genomics (CG) sequencing platforms for one 
family containing two affected male brothers,  aged 10 
and  12,  with  severe  intellectual  disability  and  very 
distinctive facial features. High accuracy and sensitivity 
is of particular importance in the context of detecting or 
discovering the genetic influencers of human diseases.
Fig.  1   (A)  Pedigree  structure  of  all  individuals  in  the 
family  that  were  sequenced  during  the  course  of  this 
study.  Individuals  with  a  star  next  to  their  number 
indicates that their whole genomes were sequenced with 
both  the  Complete  Genomics  sequencing  and  analysis 
pipeline as well as with Illumina sequencing. 
•  Human sequence variation ranges in manifestation from 
differences that can be detected at the single nucleotide 
level, to whole chromosome differences (Fig 2).
•  Conclusions:  Analyzing  multi-generational  pedigrees 
using multiple orthogonal bioinformatics pipelines using 
two  sequencing  platforms  can  reliably  reveal  human 
sequence variants that may be important in rare disease. 
We have found a number of sequence variants that may 
play  a  role  in  the  rare  disease  described  here  and 
highlight a variant in TAF1. Our findings are consistent 
with  the  literature  on  the  importance  of  the  TF11D 
complex in developmental delay and ID.
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Fig. 2  A conceptual map of human sequence variation, 
and a list of the bioinformatics programs we used during 
the course of our study.
•  The two affected male brothers have severe intellectual 
disability,  autism-like behavior,  attention deficit  issues, 
and very distinctive facial features (Fig. 1C), including 
broad, upturned nose, sagging cheeks, downward sloping 
palpebral  fissures,  relative  hypertelorism,  high-arched 
palate, and prominent ears. 
•  The  mother  of  the  two  affected  (Fig.  1A,  II-2)  was 
shown  to  have  99:1  x-chromosome  inactivation  (Fig. 
1B).
•  14 unique INDELS and SNVs were discovered using two 
different prioritization (Fig. 3A).   
•  The  TAF1  variant  arose  in  this  family  as  a  de-novo 
variant  on  the  X-chromosome of  the  mother  (Fig.  1A, 
II-2) of the two affected children (as it is not found in any 
of  the  other  members  of  the  family)  and  was  then 
transmitted to both of them.  The mother also is the only 
female in the family to exhibit extreme X-chromosome 
skewing.  
•  The  transcription  factor  initiation  complex  TF11D  has 
recently been implicated in playing a role in intellectual 
disability and developmental delay, and TAF1 represents 
the largest known subunit of this multi-protein complex, 
and  this  variant  falls  within  a  conserved  region  of  the 
protein (Fig 3B).
Fig. 3
•  We  sought  to  identify  variants  following  de-novo, 
autosomal recessive and x-linked models of transmission 
that may be contributing, together or alone, to the disease 
phenotype.   We  used  several  methods  to  prioritize  and 
identify possible disease-contributory germ-line variants, 
in-cluding VAAST, Golden Helix SVS v8.1.4, ANNOVAR 
(2013Aug23 version), and GEMINI v0.9.1.
Presentation of the phenotype 
Bioinformatics analysis 
Results 
•  We found a 2.4 to 14.0 mean fold difference in the number 
of variants detected as being relevant for vari-ous disease 
models when using different sets of sequencing data. 
